Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome

Clinical Biochemistry

Volumn 46, Issue 3, 2013, Pages 225-229

  Hoenigl, Martin ^a   Raggam, Reinhard B ^a   Wagner, Jasmin ^a   Valentin, Thomas ^a   Leitner, Eva ^a   Seeber, Katharina ^a   Zollner Schwetz, Ines ^a   Krammer, Werner ^a   Prüller, Florian ^a   Grisold, Andrea J ^a   Krause, Robert ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Bacteremia; Diagnostic accuracy; IL 6; PCT; SIRS; SuPAR

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; PROCALCITONIN; UROKINASE RECEPTOR;

AGED; ARTICLE; BACTEREMIA; BLOOD CULTURE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GLOMERULUS FILTRATION RATE; HEMATOLOGIC DISEASE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; NEUTROPHIL COUNT; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; SURVIVAL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BACTEREMIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CASE-CONTROL STUDIES; ESCHERICHIA COLI; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INTERLEUKIN-6; KLEBSIELLA; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84871945503     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.11.004     Document Type: Article

References (27)

1. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
2. Rowther F.B., Rodrigues C.S., Deshmukh M.S., et al. Prospective comparison of eubacterial PCR and measurement of procalcitonin levels with blood culture for diagnosing septicemia in intensive care unit patients. J Clin Microbiol 2009, 47:2964-2969.
3. Kofoed K., Andersen O., Kronborg G., et al. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care 2007, 11:R38.
4. Thuno M., Macho B., Eugen-Olsen J. suPAR: the molecular crystal ball. Dis Markers 2009, 27:157-172.
5. Yilmaz G., Mentese A., Kaya S., Uzun A., Karahan S.C., Koksal I. The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in Crimean-Congo hemorrhagic fever. J Clin Virol 2011, 50:209-211.
6. Andersen O., Eugen-Olsen J., Kofoed K., Iversen J., Haugaard S.B. suPAR associates to glucose metabolic aberration during glucose stimulation in HIV-infected patients on HAART. J Infect 2008, 57:55-63.
7. Rabna P., Andersen A., Wejse C., et al. Urine suPAR levels compared with plasma suPAR Levels as Predictors of post-consultation mortality risk among individuals assumed to be TB-negative: a prospective cohort study. Inflammation 2010, 33(6):374-380.
8. Perch M., Kofoed P., Fischer T.K., et al. Serum levels of soluble urokinase plasminogen activator receptor is associated with parasitemia in children with acute Plasmodium falciparum malaria infection. Parasite Immunol 2004, 26:207-211.
9. Toldi G., Beko G., Kadar G., et al. Soluble urokinase plasminogen activator receptor (suPAR) in the assessment of inflammatory activity of rheumatoid arthritis patients in remission. Clin Chem Lab Med 2012, 1-6.
10. Sier C.F., Sidenius N., Mariani A., et al. Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance. Lab Invest 1999, 79:717-722.
11. Riisbro R., Christensen I.J., Hogdall C., Brunner N., Hogdall E. Soluble urokinase plasminogen activator receptor measurements: influence of sample handling. Int J Biol Markers 2001, 16:233-239.
12. Wittenhagen P., Kronborg G., Weis N., et al. The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality. Clin Microbiol Infect 2004, 10:409-415.
13. Huttunen R., Syrjanen J., Vuento R., et al. Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study. J Intern Med 2011, 270:32-40.
14. Molkanen T., Ruotsalainen E., Thorball C.W., Jarvinen A. Elevated soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 2011, 30:1417-1424.
15. Yilmaz G., Koksal I., Karahan S.C., Mentese A. The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in systemic inflammatory response syndrome. Clin Biochem 2011, 44:1227-1230.
16. Alberti C., Brun-Buisson C., Burchardi H., et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002, 28:108-121.
17. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. Chest 2009, 136:e28.
18. Levey A.S., Coresh J., Greene T., et al. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007, 53:766-772.
19. Moller H.J., Moestrup S.K., Weis N., et al. Macrophage serum markers in pneumococcal bacteremia: prediction of survival by soluble CD163. Crit Care Med 2006, 34:2561-2566.
20. Koch A., Voigt S., Kruschinski C., et al. Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Crit Care 2011, 15:R63.
21. Koch A., Tacke F. Why high suPAR is not super - diagnostic, prognostic and potential pathogenic properties of a novel biomarker in the ICU. Crit Care 2011, 15:1020.
22. Donadello K., Scolletta S., Covajes C., Vincent J.L. suPAR as a prognostic biomarker in sepsis. BMC Med 2012, 10:2.
23. Kofoed K., Eugen-Olsen J., Petersen J., Larsen K., Andersen O. Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factor. Eur J Clin Microbiol Infect Dis 2008, 27:375-383.
24. Pisinger C., Ladelund S., Eugen-Olsen J. Influence of Lifestyle on suPAR Levels. The Inter99 Study 2012, [http://suparnostic.com/images/stories/3rd_supar_symposium_2012_abstracts_program.pdf:11-11].
25. Eugen-Olsen J., Andersen O., Linneberg A., et al. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. J Intern Med 2010, 268:296-308.
26. Haugaard S.B., Andersen O., Hansen T.W., et al. The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and men. Diabet Med 2012, 29(4):479-487.
27. [Accessed on Sep 20th, 2012]. http://suparnostic.com/Result-Interpretation.